Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders
Year: 2014
Type: review
Source: Nature Reviews Drug Discovery
DOI: 10.1038/nrd4308
Institutions: Vanderbilt University Medical Center, Vanderbilt University
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: bronze
Awards: Metabotropic Glutamate Receptors in the Basal Ganglia, Partial Antagonists of mGluR5 for Treatment of Cocaine Addiction, The Vanderbilt Specialized Chemistry Center for Accelerated Probe Development, Selective M1 mAChR allosteric modulators for the treatment of schizophrenia, Computational Design of Protein-Ligand Interfaces - a Therapeutic Strategy, Membrane Protein Structure Elucidation from Limited Magnetic Resonance Data, Cheminformatics of Allosteric mGluR Modulation promotes Therapeutic Development, Muscarinic Receptor Activators as Antipsychotic Agents, Udall Parkinson's Disease Center at Emory University: Circuitry to Therapy, Development of mGIuR5 NAMS for Treatment of Major Depression, G7769517049, Small Molecule Probes to Investigate Structure and Function of Y Receptors, Functions of Metabotropic Glutamate Receptor Subtypes, Regulation of Signaling by mGluR5, Functions of Metabotropic Glutamate Receptor Subtypes
OpenAlex ID: W2057916169
